Literature DB >> 14566337

Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.

Gregory Lizée1, Genc Basha, Jacqueline Tiong, Jean-Pierre Julien, Meimei Tian, Kaan E Biron, Wilfred A Jefferies.   

Abstract

Dendritic cells (DCs) can present extracellularly derived antigens in the context of major histocompatibility complex (MHC) class I molecules, a process called cross-presentation. Although recognized to be important for priming of T cell responses to many viral, bacterial and tumor antigens, the mechanistic details of this alternative antigen-presentation pathway are poorly understood. We demonstrate here the existence of an endolysosomal compartment in DCs where exogenously derived peptides can be acquired for presentation to T cells, and show that the MHC class I cytoplasmic domain contains a tyrosine-based targeting signal required for routing MHC class I molecules through these compartments. We also report that transgenic mice expressing H-2K(b) with a tyrosine mutation mount inferior H-2K(b)-restricted cytotoxic T lymphocyte responses against two immunodominant viral epitopes, providing evidence of a crucial function for cross-priming in antiviral immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566337     DOI: 10.1038/ni989

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  64 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 2.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

Review 3.  Recent advances in dendritic cell biology.

Authors:  Sylvia Adams; David W O'Neill; Nina Bhardwaj
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

Review 4.  Recent advances in dendritic cell biology.

Authors:  Sylvia Adams; David W O'Neill; Nina Bhardwaj
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

5.  Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.

Authors:  Roberta Schiavo; Dolgor Baatar; Purevdorj Olkhanud; Fred E Indig; Nicholas Restifo; Dennis Taub; Arya Biragyn
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

6.  Tubulation of endosomal structures in human dendritic cells by Toll-like receptor ligation and lymphocyte contact accompanies antigen cross-presentation.

Authors:  Ewoud B Compeer; Thijs W H Flinsenberg; Louis Boon; Mirjam E Hoekstra; Marianne Boes
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

7.  The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells.

Authors:  Liyun Zou; Jingran Zhou; Jinyu Zhang; Jingyi Li; Na Liu; Linlin Chai; Na Li; Ting Liu; Liqi Li; Zhunyi Xie; Hongli Liu; Ying Wan; Yuzhang Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

8.  Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Authors:  Tiziana Di Pucchio; Bithi Chatterjee; Anna Smed-Sörensen; Sandra Clayton; Adam Palazzo; Monica Montes; Yaming Xue; Ira Mellman; Jacques Banchereau; John E Connolly
Journal:  Nat Immunol       Date:  2008-03-30       Impact factor: 25.606

9.  Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.

Authors:  Rupal Ramakrishnan; Vladimir A Tyurin; Vladimir A Tuyrin; Filippo Veglia; Thomas Condamine; Andrew Amoscato; Dariush Mohammadyani; Joseph J Johnson; Lan Min Zhang; Judith Klein-Seetharaman; Esteban Celis; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

Review 10.  MHC class I assembly: out and about.

Authors:  Malini Raghavan; Natasha Del Cid; Syed Monem Rizvi; Larry Robert Peters
Journal:  Trends Immunol       Date:  2008-09       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.